These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


300 related items for PubMed ID: 19197812

  • 1. [Mechanisms and potential of the therapeutic stimulation of arteriogenesis].
    Schirmer SH, van Royen N, Laufs U, Böhm M.
    Dtsch Med Wochenschr; 2009 Feb; 134(7):302-6. PubMed ID: 19197812
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interferon-beta signaling is enhanced in patients with insufficient coronary collateral artery development and inhibits arteriogenesis in mice.
    Schirmer SH, Fledderus JO, Bot PT, Moerland PD, Hoefer IE, Baan J, Henriques JP, van der Schaaf RJ, Vis MM, Horrevoets AJ, Piek JJ, van Royen N.
    Circ Res; 2008 May 23; 102(10):1286-94. PubMed ID: 18420941
    [Abstract] [Full Text] [Related]

  • 4. A new intra-arterial delivery platform for pro-arteriogenic compounds to stimulate collateral artery growth via transforming growth factor-beta1 release.
    Grundmann S, van Royen N, Pasterkamp G, Gonzalez N, Tijsma EJ, Piek JJ, Hoefer IE.
    J Am Coll Cardiol; 2007 Jul 24; 50(4):351-8. PubMed ID: 17659203
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential effects of MCP-1 and leptin on collateral flow and arteriogenesis.
    Schirmer SH, Buschmann IR, Jost MM, Hoefer IE, Grundmann S, Andert JP, Ulusans S, Bode C, Piek JJ, van Royen N.
    Cardiovasc Res; 2004 Nov 01; 64(2):356-64. PubMed ID: 15485696
    [Abstract] [Full Text] [Related]

  • 12. Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation?
    Lekas M, Lekas P, Latter DA, Kutryk MB, Stewart DJ.
    Curr Opin Cardiol; 2006 Jul 01; 21(4):376-84. PubMed ID: 16755208
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Stretch-induced activation of the transcription factor activator protein-1 controls monocyte chemoattractant protein-1 expression during arteriogenesis.
    Demicheva E, Hecker M, Korff T.
    Circ Res; 2008 Aug 29; 103(5):477-84. PubMed ID: 18669921
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mechanisms of arteriogenesis.
    Cai W, Schaper W.
    Acta Biochim Biophys Sin (Shanghai); 2008 Aug 29; 40(8):681-92. PubMed ID: 18685784
    [Abstract] [Full Text] [Related]

  • 17. A critical review of clinical arteriogenesis research.
    van Royen N, Piek JJ, Schaper W, Fulton WF.
    J Am Coll Cardiol; 2009 Dec 29; 55(1):17-25. PubMed ID: 20117358
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Arteriogenesis: mechanisms and modulation of collateral artery development.
    Van Royen N, Piek JJ, Schaper W, Bode C, Buschmann I.
    J Nucl Cardiol; 2001 Dec 29; 8(6):687-93. PubMed ID: 11725265
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.